How Decentralized AI is Revolutionizing Cardiac Diagnostics Worldwide Innovative AI solutions are reshaping cardiac diagnostics, facilitating access for underserved communities while addressing pressing heart health challenges globally.

How Decentralized AI is Revolutionizing Cardiac Diagnostics Worldwide #Canada #Vancouver #Heart_Disease #cardiac_diagnostics #Ventripoint

New Edwards Lifesciences Survey Reveals Gaps in Heart Health Awareness Among Older Adults A recent survey by Edwards Lifesciences highlights significant gaps in heart health awareness among older adults, emphasizing the need for proactive health discussions.

New Edwards Lifesciences Survey Reveals Gaps in Heart Health Awareness Among Older Adults #United_States #Edwards_Lifesciences #Irvine #Heart_Disease #Heart_Health

PDS Health Explores the Crucial Link Between Oral and Heart Health During American Heart Month As American Heart Month begins, PDS Health emphasizes the vital connection between oral health and heart health. Discover the importance of dental visits.

PDS Health Explores the Crucial Link Between Oral and Heart Health During American Heart Month #USA #Heart_Disease #Henderson #PDS_Health #periodontal_disease

Innovative Startup Tackles Undetected Heart Disease Risks at Morning Pitch Event At the upcoming Morning Pitch event, a promising startup focuses on early detection of heart disease risks, addressing public health challenges in the Tama region.

Innovative Startup Tackles Undetected Heart Disease Risks at Morning Pitch Event #Japan #Tokyo #Heart_Disease #Cocoromil #Morning_Pitch

New Study Confirms AISAP’s AI for Detecting Heart Disease from Ultrasound Views A recent study validates AISAP's AI technology for accurately diagnosing heart disease from just one ultrasound view, revolutionizing cardiac care.

New Study Confirms AISAP’s AI for Detecting Heart Disease from Ultrasound Views #USA #New_York #AI_Technology #Heart_Disease #AISAP

Innovative Cardiac Rehabilitation Case Study Presented at Conference by Walkey Company Walkey Company showcased their cardiac rehabilitation initiative using the Walkey device at a recent medical conference, highlighting its clinical applications.

Innovative Cardiac Rehabilitation Case Study Presented at Conference by Walkey Company #Japan #Tokyo #Heart_Disease #Cardiac_Rehabilitation #Walkey

Join the Go Red for Women Japan Health Seminar 2026: Raising Awareness About Heart Disease The Go Red for Women Japan Health Seminar 2026 aims to raise awareness about heart disease in women, featuring distinguished speakers and engaging activities.

Join the Go Red for Women Japan Health Seminar 2026: Raising Awareness About Heart Disease #Japan #Heart_Disease #Tokyo,_Osaka #Go_Red_for_Women

Innovative Study from Korea University Enhances Heart Organoid Maturation Using Magnetic Torque Technology A Korea University study reveals how magnetic torque stimulation significantly boosts the maturation of cardiac organoids, potentially transforming heart disease research and treatment.

Innovative Study from Korea University Enhances Heart Organoid Maturation Using Magnetic Torque Technology #South_Korea #Seoul #Korea_University #Heart_Disease #cardiac_organoids

Flu Vaccination: A Crucial Measure for Patients with Chronic Illnesses As winter approaches, health organizations underscore the importance of flu shots for individuals with chronic conditions like diabetes and heart disease.

Flu Vaccination: A Crucial Measure for Patients with Chronic Illnesses #USA #Heart_Disease #Various_Cities #diabetes #Flu_Shots

Genes From Our Ancestors May Shed Light on Heart Disease Today Recent findings suggest ancient genes may predispose modern humans to heart disease. Understanding these genetic links can help manage health risks today.

Genes From Our Ancestors May Shed Light on Heart Disease Today #None #Heart_Disease #Fountain_Valley #Evolutionary_Biology #Atherosclerosis

Thryv Therapeutics to Unveil Breakthrough Research at 2025 AHA Sessions in New Orleans Thryv Therapeutics will present groundbreaking preclinical findings at the American Heart Association Scientific Sessions 2025, showcasing SGK1 inhibitors' potential.

Thryv Therapeutics to Unveil Breakthrough Research at 2025 AHA Sessions in New Orleans #USA #New_Orleans #Heart_Disease #Thryv_Therapeutics #SGK1_inhibitors

Creating a Society Where Heart Disease is No Problem: Final Report of the With Heart Project Join us for the final report of the With Heart Project, which strives to create a society accepting heart disease. Hear insights and share experiences with key stakeholders.

Creating a Society Where Heart Disease is No Problem: Final Report of the With Heart Project #Japan #Tokyo #Heart_Disease #PPI #With_Heart_Project

Interventional Cardiology Devices Market Growth Projections and Trends Up to 2033 The Interventional Cardiology Devices Market is projected to grow significantly, reaching $39 billion by 2033, driven by technological advancements and rising heart disease cases.

Interventional Cardiology Devices Market Growth Projections and Trends Up to 2033 #None #Heart_Disease #Interventional_Cardiology #Cardiology_Stents

Caristo's CaRi-Heart Technology Receives CPT Codes for U.S. Clinical Use Caristo Diagnostics makes strides in heart disease detection with CPT codes for the CaRi-Heart technology, advancing its clinical application in the U.S.

Caristo's CaRi-Heart Technology Receives CPT Codes for U.S. Clinical Use #United_States #Stamford #Heart_Disease #CaRi-Heart #Caristo

First Patient Treated with Hybrid iPS Cell Therapy for Cardiomyopathy iHeart Japan has successfully conducted the first treatment using their IHJ-301 hybrid therapy derived from iPS cells, paving the way for advanced heart disease interventions.

First Patient Treated with Hybrid iPS Cell Therapy for Cardiomyopathy #Japan #Heart_Disease #Kyoto #iPS_Cells #IHJ-301

OMRON Healthcare Urges Awareness of AFib and Heart Disease Risks Amidst Rising Mortality Rates OMRON Healthcare emphasizes the need for public awareness on arrhythmias and heart disease harm, citing alarming research findings from the CDC.

OMRON Healthcare Urges Awareness of AFib and Heart Disease Risks Amidst Rising Mortality Rates #United_States #Heart_Disease #Hoffman_Estates #Omron_Healthcare #AFib

Meanwhile, that “tiny” NIH line is what powered checkpoint inhibitors for #cancer, continuous glucose monitors for #diabetes, endovascular thrombectomy for #stroke, statins & PCSK9 inhibitors for #heart_disease, and battlefield-ready regenerative foams for #trauma.

Heart & Stroke Awareness Campaign: Susan Lucci's Inspiring Journey Mediaplanet's Heart & Stroke campaign aims to educate on heart disease and stroke, featuring Susan Lucci's compelling survival story to inspire awareness and action.

Heart & Stroke Awareness Campaign: Susan Lucci's Inspiring Journey #USA #New_York #Heart_Disease #Stroke_Awareness #Susan_Lucci

Understanding the Heart, Kidney, and Metabolic Health Risks Women Face Many women are unaware of the health risks they face regarding heart disease, kidney health, and metabolic conditions like diabetes. It’s crucial to understand these issues.

Understanding the Heart, Kidney, and Metabolic Health Risks Women Face #United_States #Heart_Disease #Women's_Health #CKM_syndrome #Mission,_Kan.

Women and Heart Disease: Understanding the Critical Differences in Symptoms and Risks Heart disease affects women differently than men, often leading to missed symptoms. Understanding these differences can save lives.

Women and Heart Disease: Understanding the Critical Differences in Symptoms and Risks #United_States #Mission #Heart_Disease #Women's_Health #Cholesterol

Connection Between Common Plastics and Heart Disease Deaths Identified A new analysis reveals that daily exposure to certain chemicals in plastics is linked to over 356,000 heart disease deaths globally in 2018, highlighting urgent health concerns.

Connection Between Common Plastics and Heart Disease Deaths Identified #United_States #New_York #Heart_Disease #DEHP #Phthalates

Eli Lilly's Lepodisiran Shows Promise in Reducing Heart Disease Risk Factors Significantly Eli Lilly's lepodisiran has demonstrated an impressive reduction in genetically inherited heart disease risk factor lipoprotein(a) by nearly 94% in clinical trials, offering hope for millions at risk.

Eli Lilly's Lepodisiran Shows Promise in Reducing Heart Disease Risk Factors Significantly #United_States #Indianapolis #Heart_Disease #Eli_Lilly #Lepodisiran

#Obesity increases the risk of #chronic_diseases like #diabetes, #heart_disease, and #hypertension by causing inflammation and metabolic imbalances. Managing weight through a #healthy_diet and #exercise can help prevent these conditions. www.mrmed.in/health-libra...

Caristo's FDA Clearance Marks a Milestone for AI in Heart Attack Prevention Caristo Diagnostics has received FDA 510(k) clearance for its CaRi-Plaque™ technology, transforming heart attack prevention with AI-driven diagnostics.

Caristo's FDA Clearance Marks a Milestone for AI in Heart Attack Prevention #USA #Stamford #Heart_Disease #Caristo_Diagnostics #CaRi-Plaque

Gorillas with heart disease have altered gut microbiomes, study shows Heart disease is the leading cause of death in zoo gorillas, but its origins remain unknown. Researchers from the University of Minnesota, in collaboration with national and international partners, ha...

#Gorillas with #heart_disease have altered #gut #microbiomes, study shows.

phys.org/news/2025-03...

Cleerly Secures $106 Million to Transform Heart Disease Management with AI Technology Cleerly has successfully closed a $106 million funding round led by Insight Partners to enhance heart disease care through AI technology.

Cleerly Secures $106 Million to Transform Heart Disease Management with AI Technology #USA #Denver #Cleerly #Heart_Disease #Insight_Partners

New Study Sheds Light on Heart Disease Risk Linked to Cancer Treatments Recent research reveals that certain cancer therapies may inadvertently increase the risk of heart disease. This highlights the need for patient monitoring post-treatment.

New Study Sheds Light on Heart Disease Risk Linked to Cancer Treatments #USA #New_York #Cancer_Treatment #Heart_Disease #immune_checkpoint

Cleerly Showcases Cutting-Edge AI Innovations in Cardiovascular Imaging at RSNA 2024 Cleerly presents its advanced AI-driven cardiovascular imaging solutions at RSNA 2024, enhancing detection and treatment of heart disease.

Cleerly Showcases Cutting-Edge AI Innovations in Cardiovascular Imaging at RSNA 2024 #United_States #Chicago #Cleerly #AI-CT_Imaging #Heart_Disease